RE: Marie Celeste21 Apr 2022 10:08
I tend to agree with that Red. Whether it's needed or not, and whether it's a raise or a loan facility, the uncertainty isn't doing the SP any favours.
My opinion is positive in that I think that there is a revenue trajectory and they are waiting to demonstrate this to the market and any would-be backers. Then 2nd part of the equation is whether they want to/need to accelerate growth or whether the drug itself will do this. They appear to have plenty of payer coverage but who knows how fast this knowledge spreads amongst the medical community. It started from zero presence so a lot to ask.
The picture is still unclear but as mentioned yesterday, this story is very soon, to unfold for us.
Regards